MIRA Pharmaceuticals increases ATM offering capacity by $15.2M

MIRA PHARMACEUTICALS, INC.

Filed prospectus supplement to raise additional $15,241,591 via ATM offering.
Previously sold $7,034,658 of common stock under same agreement with Rodman & Renshaw.
Agreement dated August 12, 2024, amended September 24, 2024.

item 8.01 item 9.01

MIRA PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001493152-25-026445

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.